Abstract:Endometriosis is a chronic, inflammatory gynecological condition defined by the presence of endometrial-like epithelium and/or stroma outside of the uterus ([Fig. 1]). Endometriosis exists on a spectrum of presentations and can be further classified by location into superficial peritoneal (lesions involving the peritoneal surface), ovarian (formation of endometriomas or "chocolate cysts" on the ovaries typically containing ectopic tissue and bloody fluid), deep (nodular implantation of tissue into the peritoneal surface with associate fibrosis), extra-abdominal (outside the abdomen), and iatrogenic (dissemination of endometrium following surgery).[1] The clinical presentation of endometriosis is variable, and depends on the subtype of endometriosis and location(s) of involvement. While up to 20 to 25% of patients are asymptomatic, common clinical features include chronic pelvic pain which worsens prior to the onset of menses, dysmenorrhea, dyspareunia, and infertility.[2] [3] Despite its strong link to infertility in women, the pathophysiology of endometriosis remains poorly understood. Postulated to be a combination of the development of a pro-invasive inflammatory milieu by endometrial cells and retrograde flux of endometrial tissue through the fallopian tubes into and beyond the endometrial cavity, there remains a lack of consensus regarding the etiology of endometriosis.[1] Furthermore, this explanation does not account for the disparity between women with retrograde flow, seen in up to 90% of women, and the eventual development of endometriosis.[4] With studies approximating the prevalence of endometriosis between 25 and 50% in infertile women, optimization of obstetric outcomes is a priority among patients seeking treatment.[3] While surgical outcomes typically improve symptoms and increase the pregnancy rate, they come with appreciable risk of damage to the ovaries and diminished ovarian reserve.[5] Given the significant morbidity and impairment in fertility associated with endometriosis, its examination as a clinical entity, as well as the limitations and advantages in its treatment, is warranted. Article published online: 24 January 2024 © 2023. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Growing evidence that endometriosis is a systemic disease

A comprehensive cell profiling reveals new cell subtypes and immune dysfunction in peritoneal fluid of endometriosis

The Association between Endometriosis and Immunological diseases

Evidence in Support for the Progressive Nature of Ovarian Endometriomas

Recent insights explaining susceptibility to endometriosis-From genetics to environment

Evidence for a Hypercoagulable State in Women with Ovarian Endometriomas

Endometriosis: Update of Pathophysiology, (Epi) Genetic and Environmental Involvement

The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights

Immune and endocrine regulation in endometriosis: what we know

IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors

Future Biological Perspectives for Diagnosis and Treatment

Endometriosis and the Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Pathophysiology: A Narrative Review of the Literature

The significance of immune microenvironment in patients with endometriosis

The interplay between systemic inflammatory factors and endometriosis: A bidirectional mendelian randomization study

Do inflammatory factors play a significant role in etiopathogenesis of endometrial cysts? Part 1

Endometriosis: An Overview

Endometriosis: A Malignant Fingerprint

The Epigenetics of Endometriosis

Pathogenesis Based Diagnosis and Treatment of Endometriosis

The role of regulatory T-cells in the development of endometriosis

The Dysregulated IL-23/TH17 Axis in Endometriosis Pathophysiology